Skip to main content

Stability of pain-related medications, metabolites, and illicit substances in urine.

Gonzales E, Ng G, Pesce A, West C, West R, Mikel C, Latyshev S, Almazan P

Publication: Clin Chim Acta (2013) • Vol 416 • Page 80-5PMID: 23200822View on PubMed

Purpose

This paper investigated the effects of storage at 4˚C or -20˚C with or without a freeze-thaw cycle on the levels of 33 compounds that were spiked into urine.

Conclusion

Levels of all analytes remained within 30% of initial levels regardless of storage temperature, storage duration, or freeze-thaw cycling with the exception of 7-amino-clonazepam which declined by 40-60% with storage at 4˚C, but changed by <15% during storage at -20˚C, regardless of freeze-thaw cycling. 

Studies (1)

Purpose

This study investigated the effects of storage at 4˚C or -20˚C with or without a freeze-thaw cycle on the levels of 33 compounds that were spiked into urine from one healthy patient. Thirty-three different medications, metabolites, and illicit drugs were added at two different concentrations to urine aliquots. Two aliquots at each concentration were analyzed immediately or after 2, 3, and 6 months at 4 and -20˚C. Additional aliquots stored at -20˚C were analyzed with a freeze-thaw cycle. Levels were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS) for each time-point and the percent difference from aliquots not subjected to storage was determined.

Summary of Findings

Changes in levels of morphine, hydromorphone, EDDP, fentanyl, and alpha-hydrocyalprazolam were limited to less than 10%, regardless of storage temperature, storage duration, and freeze-thaw cycling. Levels of codeine, hydrocodone, oxycodone, oxymorphone, norfentanyl, meperidine, normeperidine, propoxyphene, tramadol, tenpentadol, and nordiazepam changed by less than 20% regardless of storage temperature or duration or freeze-thaw cycling. Although changes in lorezapam, buprenorphine, and norbuprenorphine were generally less than 20%, they declined by 21%,25% and 24%, respectively after 2 months of storage at -20˚C when subjected to a freeze-thaw cycle. Levels of methadone declined by >20% when stored at 4 or -20˚C for 2 months with a freeze-thaw cycle, but changes were limited to less than 10% when stored for longer, regardless of freeze-thaw-cycling. Similarly, levels of norpropoxyphene declined by >20% when stored at 4 or -20˚C for 2 months, regardless of freeze-thaw cycling and when stored at -20˚C for 3 months with freeze-thaw cycling, but declined by less than 10% when stored at 4 or -20˚C for 6 months, regardless of freeze-thaw cycling. Levels of 7-amino-clonazepam declined significantly with storage at 4˚C (-43% after 2 months, -52% after 3 months, and -58% after 6 months), but changed by <15% during storage at -20˚C, regardless of freeze-thaw cycling. 

  • Biospecimens

    FluidUrine
  • Preservation Types

    FrozenNone (Fresh)
  • Diagnoses

    Normal
  • Platforms

    Small moleculeLC-MS or LC-MS/MS
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    StorageFreeze/thaw cycling
    0 cycles
    1 cycle
    StorageStorage duration
    0 months
    2 months
    3 months
    6 months
    StorageStorage temperature
    -20˚C
    4˚C